Azzad Asset Management Inc. ADV increased its holdings in Danaher Corporation (NYSE:DHR – Free Report) by 59.2% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,539 shares of the conglomerate’s stock after purchasing an additional 9,494 shares during the quarter. Azzad Asset Management Inc. ADV’s holdings in Danaher were worth $4,842,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also added to or reduced their stakes in DHR. Sivia Capital Partners LLC grew its position in Danaher by 6.3% during the second quarter. Sivia Capital Partners LLC now owns 2,009 shares of the conglomerate’s stock valued at $397,000 after purchasing an additional 119 shares in the last quarter. First Trust Advisors LP lifted its position in Danaher by 34.5% in the 2nd quarter. First Trust Advisors LP now owns 55,418 shares of the conglomerate’s stock worth $10,947,000 after buying an additional 14,217 shares in the last quarter. Main Street Financial Solutions LLC boosted its stake in shares of Danaher by 40.2% during the 2nd quarter. Main Street Financial Solutions LLC now owns 3,088 shares of the conglomerate’s stock valued at $610,000 after buying an additional 886 shares during the period. Ieq Capital LLC boosted its stake in shares of Danaher by 64.2% during the 2nd quarter. Ieq Capital LLC now owns 75,714 shares of the conglomerate’s stock valued at $14,957,000 after buying an additional 29,592 shares during the period. Finally, HUB Investment Partners LLC grew its holdings in shares of Danaher by 30.7% during the 2nd quarter. HUB Investment Partners LLC now owns 1,383 shares of the conglomerate’s stock valued at $273,000 after acquiring an additional 325 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.
Danaher Stock Performance
DHR opened at $195.75 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. The company has a market cap of $138.54 billion, a PE ratio of 37.86, a price-to-earnings-growth ratio of 2.43 and a beta of 0.79. The stock has a 50-day moving average of $180.18 and a 200-day moving average of $199.48. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.
Danaher Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.8%. Danaher’s dividend payout ratio (DPR) is currently 30.95%.
Analysts Set New Price Targets
A number of equities analysts have recently weighed in on the stock. Barclays dropped their price target on shares of Danaher from $250.00 to $230.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 14th. Citigroup initiated coverage on Danaher in a research note on Tuesday, May 26th. They issued a “buy” rating and a $230.00 target price on the stock. HSBC dropped their target price on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research report on Wednesday, June 3rd. JPMorgan Chase & Co. reduced their price target on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Finally, Wolfe Research cut Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating, four have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $233.52.
Read Our Latest Analysis on DHR
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Further Reading
- Five stocks we like better than Danaher
- PriceSmart Stock Eyes $220 as Chile Expansion Fuels Growth
- Dollar Tree’s Turnaround Is Starting to Take Root
- Why Levi’s Digital Strategy Is Paying Off in a Big Way
- Constellation Brands: Beer Growth and Buybacks Mask Stock’s Slump
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
